These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3015002)

  • 1. Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.
    Karlström AR; Källander CF; Abele G; Larsson A
    Antimicrob Agents Chemother; 1986 Jan; 29(1):171-4. PubMed ID: 3015002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of four acyclic guanosine analogs by herpes simplex virus type 2 thymidine kinase.
    Larsson A; Tao PZ
    Antimicrob Agents Chemother; 1984 Apr; 25(4):524-6. PubMed ID: 6329085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.
    Abele G; Karlström A; Harmenberg J; Shigeta S; Larsson A; Lindborg B; Wahren B
    Antimicrob Agents Chemother; 1987 Jan; 31(1):76-80. PubMed ID: 3032092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase.
    Cheng YC; Tsou TY; Hackstadt T; Mallavia LP
    J Virol; 1979 Jul; 31(1):172-7. PubMed ID: 228052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of oxetanocins against varicella-zoster virus.
    Sakuma T; Saijo M; Suzutani T; Yoshida I; Saito S; Kitagawa M; Hasegawa S; Azuma M
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1512-4. PubMed ID: 1656865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-zoster virus thymidine kinase. Characterization and substrate specificity.
    Roberts GB; Fyfe JA; McKee SA; Rahim SG; Daluge SM; Almond MR; Rideout JL; Koszalka GW; Krenitsky TA
    Biochem Pharmacol; 1993 Dec; 46(12):2209-18. PubMed ID: 8274154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
    Abele G; Eriksson B; Harmenberg J; Wahren B
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1137-42. PubMed ID: 2847643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and mode of inhibition of varicella-zoster virus by L-beta-5-bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil is dependent on viral thymidine kinase.
    Li L; Dutschman GE; Gullen EA; Tsujii E; Grill SP; Choi Y; Chu CK; Cheng YC
    Mol Pharmacol; 2000 Nov; 58(5):1109-14. PubMed ID: 11040060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
    Kawai H; Yoshida I; Suzutani T
    Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of protein kinase (ORF47)-deficient varicella-zoster virus strains to anti-herpesvirus nucleosides.
    Suzutani T; Ogasawara M; Shibaki T; Azuma M
    Antiviral Res; 2000 Jan; 45(1):79-82. PubMed ID: 10774592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
    El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK
    Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
    Koyano S; Suzutani T; Yoshida I; Azuma M
    Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 1,2,4-triazole and purine acyclic cyclopropane nucleoside analogues: synthesis, antiviral and cytostatic activity evaluations.
    Benci K; Suhina T; Mandić L; Pavelić SK; Paravić AT; Pavelić K; Balzarini J; Wittine K; Mintas M
    Antivir Chem Chemother; 2011 Jul; 21(6):221-30. PubMed ID: 21730369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
    Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
    Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine.
    Ericson AC; Larsson A; Aoki FY; Yisak WA; Johansson NG; Oberg B; Datema R
    Antimicrob Agents Chemother; 1985 May; 27(5):753-9. PubMed ID: 2990325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):7-10. PubMed ID: 3022711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2'-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase.
    Balzarinia J; Degrève B; Zhu C; Durini E; Porcu L; De Clercq E; Karlsson A; Manfredini S
    Biochem Pharmacol; 2001 Mar; 61(6):727-32. PubMed ID: 11266658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase.
    Suzutani T; Davies LC; Honess RW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1011-6. PubMed ID: 8389797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.